SEC Filings

SEC Filings

Filing date Form Description Filing Group View
CERTNAS

CERTNAS

Other
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.INS - XBRL INSTANCE DOCUMENT
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
5

Annual filing director officer or owner of more than ten percent.

3,4,5
View HTML

Data provided by Kaleidoscope.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com